| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,§
* Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030, USA;
Huffington Center on Aging, Houston, Texas 77030, USA;
USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA; and
§ Department of Cardiovascular Sciences, Baylor College of Medicine, Houston, Texas 77030, USA
1Correspondence: Department of Cell Biology, Baylor College of Medicine, Houston, TX 77030, USA. E-mail: schwartz{at}bcm.tmc.edu
In the present study we determined the long-term effects of persistent, local insulin-like growth factor I (IGF-I) expression on cardiac function in the SIS2 transgenic mouse. Cardiac mass/tibial length was increased in SIS2 mice by 10 wk of age; this cardiac hypertrophy became more pronounced later in life. Peak aortic outflow velocity, a correlate of cardiac output, was increased at 10 wk in SIS2 mice but was decreased at 52 wk. 72 wk SIS2 mouse hearts exhibited wide variability in the extent of cardiac hypertrophy and enlargement of individual cardiac myofibers. Sirius red staining revealed increased fibrosis in 72 wk SIS2 hearts. Persistent local IGF-I expression is sufficient to initially induce an analog of physiological cardiac hypertrophy in which peak aortic outflow velocity is increased relative to controls in the absence of any observed detrimental histological changes. However, this hypertrophy progresses to a pathological condition characterized by decreased systolic performance and increased fibrosis. Our results confirm the short-term systolic performance benefit of increased IGF-I, but our demonstration that IGF-I ultimately diminishes systolic performance raises doubt about the therapeutic value of chronic IGF-I administration. Considering these findings, limiting temporal exposure to IGF-I seems the most likely means of delivering IGF-I's potential benefits while avoiding its deleterious side effects.—Delaughter, M. C., Taffet, G. E., Fiorotto, M. L., Entman, M. L., Schwartz, R. J. Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice.
Key Words: IGF-I • SIS2 transgene • systolic function • hypertension
This article has been cited by other articles:
|
|
 |
|
  M. Taniike, O. Yamaguchi, I. Tsujimoto, S. Hikoso, T. Takeda, A. Nakai, S. Omiya, I. Mizote, Y. Nakano, Y. Higuchi, et al. Apoptosis Signal-Regulating Kinase 1/p38 Signaling Pathway Negatively Regulates Physiological Hypertrophy Circulation, January 29, 2008; 117(4): 545 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Reddy, D. Amador-Noguez, G. J. Darlington, B. A. Scholz, L. H. Michael, C. J. Hartley, M. L. Entman, and G. E. Taffet Cardiac Function in Young and Old Little Mice J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2007; 62(12): 1319 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Santini, L. Tsao, L. Monassier, C. Theodoropoulos, J. Carter, E. Lara-Pezzi, E. Slonimsky, E. Salimova, P. Delafontaine, Y.-H. Song, et al. Enhancing Repair of the Mammalian Heart Circ. Res., June 22, 2007; 100(12): 1732 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ahuja, P. Sdek, and W. R. MacLellan Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration Physiol Rev, April 1, 2007; 87(2): 521 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Shiojima and K. Walsh Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway Genes & Dev., December 15, 2006; 20(24): 3347 - 3365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Oldroyd, Y. Miyamoto, A. Moir, T. S. Johnson, A. M. El Nahas, and J. L. Haylor An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy Am J Physiol Renal Physiol, March 1, 2006; 290(3): F695 - F702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Kang Cardiac Hypertrophy: A Risk Factor for QT-Prolongation and Cardiac Sudden Death Toxicol Pathol, January 1, 2006; 34(1): 58 - 66. [Abstract] [PDF]
|
|
|
|
|
|
L. Groban, N. A. Pailes, C. D. L. Bennett, C. S. Carter, M. C. Chappell, D. W. Kitzman, and W. E. Sonntag Growth Hormone Replacement Attenuates Diastolic Dysfunction and Cardiac Angiotensin II Expression in Senescent Rats J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2006; 61(1): 28 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ponten, E. Bergsten Folestad, K. Pietras, and U. Eriksson Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice Circ. Res., November 11, 2005; 97(10): 1036 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. R. Barton, L. E. Felkin, E. J. Birks, M. E. Cullen, N. R. Banner, S. Grindle, J. L. Hall, L. W. Miller, and M. H. Yacoub Myocardial Insulin-Like Growth Factor-I Gene Expression During Recovery From Heart Failure After Combined Left Ventricular Assist Device and Clenbuterol Therapy Circulation, August 30, 2005; 112(9_suppl): I-46 - I-50. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Schakman, H. Gilson, V. de Coninck, P. Lause, J. Verniers, X. Havaux, J. M. Ketelslegers, and J. P. Thissen Insulin-Like Growth Factor-I Gene Transfer by Electroporation Prevents Skeletal Muscle Atrophy in Glucocorticoid-Treated Rats Endocrinology, April 1, 2005; 146(4): 1789 - 1797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Harrison, C. R. Roberts, D. B. Hood, M. Sweeney, J. M. Gould, E. W. Bush, and T. A. McKinsey The CRM1 Nuclear Export Receptor Controls Pathological Cardiac Gene Expression Mol. Cell. Biol., December 15, 2004; 24(24): 10636 - 10649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G Proud Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy Cardiovasc Res, August 15, 2004; 63(3): 403 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P.M van Empel and L. J De Windt Myocyte hypertrophy and apoptosis: a balancing act Cardiovasc Res, August 15, 2004; 63(3): 487 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. McMullen, T. Shioi, W.-Y. Huang, L. Zhang, O. Tarnavski, E. Bisping, M. Schinke, S. Kong, M. C. Sherwood, J. Brown, et al. The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110{alpha}) Pathway J. Biol. Chem., February 6, 2004; 279(6): 4782 - 4793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. N. Olson and M. D. Schneider Sizing up the heart: development redux in disease Genes & Dev., August 15, 2003; 17(16): 1937 - 1956. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Iwata, Y. Katanosaka, Y. Arai, K. Komamura, K. Miyatake, and M. Shigekawa A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel J. Cell Biol., June 9, 2003; 161(5): 957 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Messi and O. Delbono Target-Derived Trophic Effect on Skeletal Muscle Innervation in Senescent Mice J. Neurosci., February 15, 2003; 23(4): 1351 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Barton, L. Morris, A. Musaro, N. Rosenthal, and H. L. Sweeney Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice J. Cell Biol., April 1, 2002; 157(1): 137 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, M. A. Borger, W. G. Williams, R. D. Weisel, D. A. G. Mickle, E. D. Wigle, and R.-K. Li Regional overexpression of insulin-like growth factor-I and transforming growth factor-{beta}1 in the myocardium of patients with hypertrophic obstructive cardiomyopathy J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 89 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Barton, L. Morris, A. Musaro, N. Rosenthal, and H. L. Sweeney Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice J. Cell Biol., April 1, 2002; 157(1): 137 - 148. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
